SEC Form D private-offering filing
AcuraStem Inc
A new SEC Form D private-offering notice from Pasadena, CA, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Biotechnology company developing antisense oligonucleotide therapies for ALS and frontotemporal dementia using its iNeuroRx disease modeling platform
Filed 2026-06-22Filed to raise $5,000,000HQ (as filed) Pasadena, CASector Biotech ✓Stage (inferred) EarlyCall status No reported sale
Source linked the Form D on EDGAR↗Website verified acurastem.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.